Clinical Trial Update: Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 study evaluating the safety and efficacy of DE-101 ophthalmic suspension in patients with dry eye.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• DE-101 ophthalmic suspension (DE-101)

Snippet

Sponsor: Santen Inc. | Conditions: Dry Eye | Phase 1, Phase 2 | Status: COMPLETED